Hypofractionated postoperative helical tomotherapy in prostate cancer: a mono-institutional report of toxicity and clinical outcomes

MLA

Cuccia F, et al. “Hypofractionated Postoperative Helical Tomotherapy in Prostate Cancer: A Mono-Institutional Report of Toxicity and Clinical Outcomes.” Cancer Management and Research, vol. ume 10, Oct. 2018, pp. 5053–60. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.0bfc2c2678d147fe9e2a9cfb6aa40609&authtype=sso&custid=ns315887.

APA

Cuccia F, Mortellaro G, Serretta V, Valenti V, Tripoli A, Gueci M, Luca N, Lo Casto A, & Ferrera G. (2018). Hypofractionated postoperative helical tomotherapy in prostate cancer: a mono-institutional report of toxicity and clinical outcomes. Cancer Management and Research, ume 10, 5053–5060.

Chicago

Cuccia F, Mortellaro G, Serretta V, Valenti V, Tripoli A, Gueci M, Luca N, Lo Casto A, and Ferrera G. 2018. “Hypofractionated Postoperative Helical Tomotherapy in Prostate Cancer: A Mono-Institutional Report of Toxicity and Clinical Outcomes.” Cancer Management and Research ume 10 (October): 5053–60. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.0bfc2c2678d147fe9e2a9cfb6aa40609&authtype=sso&custid=ns315887.